Catalyst Event
Pfizer Inc (PFE) · Other
From Akros U.S. Large Cap 500 Index (AUL500)
6/8/2026, 12:00:00 AM
CEO Albert Bourla is scheduled to speak at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026; low impact estimated as conference presentations typically result in minor price fluctuations, scheduled.
Korean Translation
CEO Albert Bourla가 2026년 6월 8일 골드만삭스 제47회 연례 글로벌 헬스케어 컨퍼런스에서 연설할 예정이며, 통상적인 컨퍼런스 발표는 주가 영향이 제한적이므로 Low로 예정됨.
Related Recent Events
Target Corp (TGT) · Earnings Release
Target's Q2 2026 earnings release is set for August 19, 2026; low importance is estimated as the date announcement itself typically has a market impact of less than 5%, scheduled.
8/19/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Other
The U.S. FDA set a PDUFA target action date for iberdomide on 2026-08-17; importance is Low as the setting of a PDUFA date is a procedural event with minor price impact.
8/17/2026, 12:00:00 AM
AST SpaceMobile Inc (ASTS) · Earnings Release
Q2 2026 earnings release and conference call for August 10, 2026, which is expected to have a medium impact by providing key financial updates, scheduled.
8/10/2026, 12:00:00 AM
Chevron Corp (CVX) · Earnings Release
Q2 2026 earnings release is scheduled for August 7, 2026; analysts forecast a significant increase in earnings due to higher oil prices and full integration of Hess assets. Market impact is estimated at Medium (5%) as earnings are a primary driver of stock volatility, scheduled.
8/7/2026, 12:00:00 AM
Akamai Technologies Inc (AKAM) · Earnings Release
Q2 2026 earnings release scheduled for 2026-08-06. Analysts forecast EPS of around $1.60 forecasted. High importance estimated due to the 26% price movement in the previous earnings release scheduled.
8/6/2026, 12:00:00 AM
Consolidated Edison Inc. (ED) · Earnings Release
Q2 2026 earnings release on 2026-08-06 is scheduled. Low importance is estimated as the primary market impact occurs on the release date, scheduled.
8/6/2026, 12:00:00 AM